If you need help accessing our website, call 855-698-9991
Affiliated Provider
Affiliated providers provide medical care at an NYU Langone location or a private practice, and are not employed by NYU Langone Health.

Jeremy R. Beitler, MD, MPH

Affiliated Provider
Affiliated providers provide medical care at an NYU Langone location or a private practice, and are not employed by NYU Langone Health.
  • Specialties: Critical Care, Pulmonary Medicine
  • Treats: Adults
  • Language: English

Positions
Board Certifications
  • American Board of Internal Medicine (Critical Care Medicine), 2014
  • American Board of Internal Medicine (Pulmonary Disease), 2013
Education and Training
  • Fellowship, Harvard Medical School- Mass General Hospital, Pulmonary and Critical Care Medicine, 2014
  • MPH from Harvard University, 2014
  • Residency, Tufts Medical Center, Internal Medicine, 2011
  • Residency, NYU School of Medicine, Internal Medicine, 2010
  • MD from New York University, 2008

Is this your profile?

Edit profile

Please call the office for information about accepted insurance plans.

Interests

Acute respiratory failure, Acute respiratory distress syndrome, Mechanical ventilation, Sedation, Clinical trials

Research Summary

Dr. Jeremy Beitler is a pulmonary intensivist and NIH-funded physician scientist with expertise in individualized management of acute respiratory failure and design/conduct of acute care clinical trials. Clinically, he cares for critically ill patients in the medical intensive care unit (MICU) at Bellevue Hospital. His NIH-funded research program focuses primarily on individualizing mechanical ventilatory support and adjunctive therapies for patients with acute respiratory failure and sepsis. He also serves as Director of the NYU Acute Respiratory Failure and Sepsis Precision Interventions to Raise Health Equity (ASPIRE) Trials Program, a national clinical trials coordinating center whose mission is to accelerate recovery from critical illness by leading equitable, high-impact clinical trials to improve public health.

Acute respiratory distress syndrome (ARDS) occurs in up to one-quarter of all critically ill adults receiving mechanical ventilation. Despite considerable advances in understanding of disease pathogenesis, ARDS remains associated with high risk of death—up to 45% mortality for severe disease. The most effective proven therapy for ARDS is to limit the degree of lung mechanical stress with each breath. Yet, how best to personalize ventilatory support to each individual patient’s unique risk of lung injury is unclear. Dr. Beitler’s research seeks to address this gap by advancing understanding of the interaction between pulmonary biomechanics and lung biology. He uses advanced techniques such as esophageal manometry, electrical impedance tomography, and quantitative ventilator waveform analysis to phenotype lung mechanics at bedside. These measures are paired with molecular biomarker signatures to identify patients at greatest risk of biophysical lung injury who may benefit from individually tailored interventions to mitigate risk of further lung injury and untoward clinical outcomes.

Dr. Beitler would like to express his gratitude to the many patients and families who have so kindly agreed to participate in clinical studies. He sincerely believes your essential support leads directly to improving survival and decreasing morbidity for patients suffering from acute respiratory failure, sepsis, and other critical illnesses.

These focus areas and their associated publications are derived from PubMed and the MeSH term library. *
represents one publication
Skip timelineRespiratory InsufficiencyCapillary PermeabilityInflammationHypnotics and SedativesRespiratory Mechanics202120242023202220212025
*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.